Urology · Charlottesville, VA
NPI
1962481556
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
155 Riverbend Dr
Charlottesville, VA, 22911
Phone (434) 295-0184
Groups this clinician bills Medicare through
Medicare paid, 2024
$374K
16,155 services
Medicare patients, 2024
911
Average age 77
Drug cost, 2024
$141K
2,150 prescriptions
Company payments, 2025
$1,988
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert B Osborne was code 81001 (clinical chemistry), 1,707 times for 836 patients. In total Robert B Osborne billed 16,155 services in 77 codes, and Medicare paid $374K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81001 Clinical Chemistry | Office | 1,707 | 836 | $3.07 | $5,244 |
| 99214 Office E&M - Established | Office | 862 | 481 | $94.08 | $81K |
| 99213 Office E&M - Established | Office | 714 | 520 | $62.21 | $44K |
| 36415 Venipuncture Blood Collection | Office | 683 | 446 | $8.64 | $5,900 |
| 51798 Ultrasound - Nonspecific | Office | 633 | 422 | $7.55 | $4,779 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 418 | 343 | $13.56 | $5,669 |
| 74018 Standard X-ray | Office | 219 | 124 | $22.22 | $4,867 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 177 | 21 | $136.54 | $24K |
| 84153 Clinical Chemistry | Office | 169 | 149 | $18.02 | $3,045 |
| 52000 Cystourethroscopy | Office | 144 | 105 | $174.68 | $25K |
| 96402 Chemotherapy Administration | Office | 89 | 25 | $25.73 | $2,290 |
| 51720 Chemotherapy Administration | Office | 74 | 12 | $65.65 | $4,858 |
| 99204 Office E&M - New | Office | 67 | 67 | $112.18 | $7,516 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 67 | 27 | $43.40 | $2,908 |
| 99211 Office E&M - Established | Office | 55 | 38 | $18.74 | $1,031 |
By year: 2022 $418K for 15,793 services; 2023 $416K for 16,078 services; 2024 $374K for 16,155 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 1,707 | 836 | $3.07 | $5,244 |
| 36415 Venipuncture Blood Collection | 683 | 446 | $8.64 | $5,900 |
| 84153 Clinical Chemistry | 169 | 149 | $18.02 | $3,045 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert B Osborne prescribed most often to Medicare patients was Silodosin, with 378 prescriptions and refills. In total Robert B Osborne wrote 2,150 Medicare prescriptions that cost $141K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Silodosin Generic | 378 | 749 | 101 | $33K |
| Finasteride Generic | 357 | 1,022 | 107 | $5,340 |
| Tamsulosin Hcl Generic | 320 | 855 | 105 | $3,964 |
| Ciprofloxacin Hcl Generic | 124 | 124 | 78 | $630 |
| Cephalexin Generic | 116 | 270 | 32 | $1,040 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 96 | 96 | 70 | $1,091 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 89 | 190 | 30 | $1,343 |
| Trimethoprim Generic | 88 | 242 | 33 | $7,744 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 70 | 78 | 60 | $329 |
| Solifenacin Succinate Generic | 59 | 101 | 20 | $2,478 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 56 | 84 | 20 | $5,184 |
| Dutasteride Generic | 44 | 95 | 13 | $1,396 |
| Potassium Citrate Er Potassium Citrate | 37 | 95 | 12 | $4,396 |
| Doxycycline Hyclate Generic | 25 | 33 | 17 | $260 |
| Myrbetriq Mirabegron | 23 | 33 | Under 11 | $15K |
Brand drugs: 120 claims; generic drugs: 2,030 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert B Osborne $1,988 ($1,988 in general payments such as food, travel and fees) from 23 companies. The largest payer was Janssen Biotech, Inc. with $284.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 9 | $284 |
| Pfizer Inc. PFE | 13 | $255 |
| Dendreon Pharmaceuticals LLC | 21 | $214 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $195 |
| Astellas Pharma US Inc 4503.T | 5 | $140 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $136 |
| Endo USA, Inc. | 4 | $99.54 |
| ABC Home Medical Supply, Inc. | 2 | $79.11 |
| Ferring Pharmaceuticals Inc. | 4 | $78.46 |
| Progenics Pharmaceuticals, Inc. | 4 | $77.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.